Drug Type Antibody |
Synonyms- |
Target |
Mechanism LAIR1 antagonists(Leukocyte-associated immunoglobulin-like receptor 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hematologic Neoplasms | Preclinical | CN | 22 Sep 2024 | |
Solid tumor | Preclinical | CN | 22 Sep 2024 |